Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.
2.

Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.

Karwa R, Woodis CB.

Ann Pharmacother. 2009 Apr;43(4):692-9. doi: 10.1345/aph.1L373. Epub 2009 Mar 18. Review.

PMID:
19299324
3.
4.

The management of hepatorenal syndrome.

Carl DE, Sanyal A.

Minerva Gastroenterol Dietol. 2009 Jun;55(2):207-26. Review.

PMID:
19305378
5.

TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?

Gülberg V, Gerbes AL.

Z Gastroenterol. 2002 Sep;40(9):823-6. Review.

PMID:
12215953
6.

[Vasoconstrictors in the treatment of hepatorenal syndrome].

Ortega R, Calahorra B, Ginès P.

Nefrologia. 2002;22 Suppl 5:56-61. Review. Spanish. No abstract available.

7.

New treatments of hepatorenal syndrome.

Arroyo V, Terra C, Ginès P.

Semin Liver Dis. 2006 Aug;26(3):254-64. Review.

PMID:
16850375
8.

[Hepatorenal syndrome: diagnosis, treatment and prevention].

Egerod Israelsen M, Gluud LL, Bendtsen F, Møller S, Krag AA.

Ugeskr Laeger. 2013 May 27;175(22):1562-6. Review. Danish.

PMID:
23721840
9.

[Hepatorenal syndrome].

Radziszewski A, Sułowicz W.

Przegl Lek. 2006;63(7):573-8. Review. Polish.

PMID:
17203812
10.

Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.

Arroyo V, Terra C, Ginès P.

J Hepatol. 2007 May;46(5):935-46. Epub 2007 Feb 27. Review. No abstract available.

PMID:
17391801
11.

Therapy insight: Management of hepatorenal syndrome.

Cárdenas A, Ginès P.

Nat Clin Pract Gastroenterol Hepatol. 2006 Jun;3(6):338-48. Review.

PMID:
16741553
12.

Hepatorenal syndrome.

Bataller R, Ginès P, Arroyo V, Rodés J.

Clin Liver Dis. 2000 May;4(2):487-507. Review.

PMID:
11232202
13.

Hepatorenal syndrome.

Kramer L, Hörl WH.

Semin Nephrol. 2002 Jul;22(4):290-301. Review.

PMID:
12118394
14.

Hepatorenal syndrome.

Biswas KD, Jain AK.

Trop Gastroenterol. 2002 Jul-Sep;23(3):113-6. Review.

PMID:
12693150
15.

Hepatorenal syndrome.

Gattoni A, Marotta F, Vangieri B, Pisani G, Cristiano F.

Clin Ter. 2004 Sep;155(9):375-89. Review.

PMID:
15700631
16.

Hepatorenal syndrome.

Guevara M, Rodés J.

Int J Biochem Cell Biol. 2005 Jan;37(1):22-6. Review.

PMID:
15381144
17.

Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.

Krag A, Borup T, Møller S, Bendtsen F.

Adv Ther. 2008 Nov;25(11):1105-40. doi: 10.1007/s12325-008-0118-7. Review.

PMID:
19018483
18.

Treatment of hepatorenal syndrome.

Kiser TH, Maclaren R, Fish DN.

Pharmacotherapy. 2009 Oct;29(10):1196-211. doi: 10.1592/phco.29.10.1196. Review.

PMID:
19792993
19.

Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.

Gentilini P, Laffi G, La Villa G, Raggi VC.

Ann Ital Med Int. 1999 Oct-Dec;14(4):264-84. Review.

PMID:
10638019
20.

Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.

Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, Garcia-Tsao G, Lee SS.

Liver Int. 2010 Aug;30(7):937-47. doi: 10.1111/j.1478-3231.2010.02272.x. Epub 2010 May 21. Review. Erratum in: Liver Int. 2010 Sep;30(8):1244.

PMID:
20492521

Supplemental Content

Support Center